Papillary thyroid carcinoma is the most common type of cancer of the thyroid gland, accounting for about 85-90% of all pediatric thyroid cancer diagnoses.
Many children will not have any symptoms when they are diagnosed or until the disease has progressed. Papillary thyroid carcinoma is most commonly found as a lump or swelling in the neck. Parents may notice a change in their child’s voice, or their child may complain of neck or throat pain, difficulty breathing, or a “lump” in their throat when swallowing. Sometimes it is identified only incidentally after a radiologic study of the neck is ordered for another reason and a lesion is seen in the thyroid gland.
Based on the results of these and possible additional studies, a treatment plan will be recommended.
As with all types of cancers, papillary thyroid carcinoma is caused by the reproduction of abnormal cells forming what is known as a tumor. The exact trigger for this growth is unknown.
The extent of surgical and medical treatment will depend on the extent of your child’s disease.
Initial treatment consists of surgical excision of all or part of the thyroid gland. Papillary thyroid carcinoma can spread through the body’s lymphatic system to lymph nodes in the neck adjacent to the thyroid gland and beyond, and surgical removal of these lymph nodes may also be required. In more advanced cases it may spread to the lungs.
Once surgical treatment is complete, radioactive iodine treatment is administered. Radioactive iodine treatment involves taking a pill that targets and kills any remaining thyroid tissue left after surgery.
In rare cases chemotherapy or external radiation may be required to treat extensive or residual disease.
American Board of Pediatrics/Endocrinology
Papillary thyroid carcinoma tends to grow slowly and respond well to treatment. The overall prognosis for pediatric patients with papillary thyroid carcinoma is excellent. Individual prognosis depends on multiple factors, particularly whether or not the disease has spread outside of the thyroid gland.
Even with disease that has spread outside of the thyroid gland, papillary thyroid carcinoma remains very treatable. Still, persistent and recurrent disease is more common in the pediatric population and may present even decades after initial treatment and a long period during which there was no evidence of disease. For this reason, multiple procedures and multiple radioactive iodine treatments may be required and long-term follow-up is critical.
While recurrent disease is actually more common in children than in adults, the outcomes in pediatric patients with recurrence are actually better. With appropriate treatment, most patients with papillary thyroid carcinoma can expect a long and fulfilling life.
Patients will need close follow-up to monitor for disease recurrence after surgery. Thyroid hormone replacement therapy is generally taken by mouth for the rest of the patient’s life to replace the hormone that the body needs but can no longer produce once the gland has been removed.